Skip to main content
Clinical Trials/NCT03607097
NCT03607097
Unknown
Not Applicable

Integral Management of Healthcare Problems Related With Drugs in Polimedicated Patients: Drug Code

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1 site in 1 country808 target enrollmentAugust 28, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Drug Related Problems
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Enrollment
808
Locations
1
Primary Endpoint
30 day readmission
Last Updated
6 years ago

Overview

Brief Summary

Background:

Although Drug- related Problems (DRPs) in polimedicated patients are a major public health problem in western countries and many of them have been considered avoidable, secondary and primary prevention policies have not been systematized, beyond pharmaceutical care programs in certain settings and on specific patients.

Objectives:

The main objective of this study is to evaluate the impact of implementing the Medication Code (CM) on patients who consult the emergency department for a DRP (secondary prevention of DRP). It is also intended to draw conclusions, based on the knowledge obtained in terms of DRP that will allow the establishment of future actions to reduce its prevalence (primary prevention actions).

Method:

A single-centre clinical trial is proposed in which adult patients will be selected to consult the Hospital Emergency Department (ED) of the Hospital de la Santa Creu i Sant Pau (HSCSP) for a primary or secondary diagnosis of DRP and will be randomised with a 1:1 distribution to be included in the medication code (intervention group) or to receive usual care (control group). The intervention will be evaluated in terms of health outcomes (ED consultations and hospital readmission).

Detailed Description

A single-centre clinical trial is proposed in which adult patients will be selected to consult the Hospital Emergency Department (ED) of the Hospital de la Santa Creu i Sant Pau (HSCSP) for a primary or secondary diagnosis of DRP and will be randomised with a 1:1 distribution to be included in the medication code (intervention group) or to receive usual care (control group). The intervention will be evaluated in terms of health outcomes (ED consultations and hospital readmission).

Registry
clinicaltrials.gov
Start Date
August 28, 2018
End Date
December 31, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \>= 18 years
  • Drug Related Problems (DRP) related to drugs from Anatomical Therapeutic Chemical (ATC) groups A, B and C

Exclusion Criteria

  • DRP due to autolytic attempt or final phase of life.
  • Denied informed consent

Outcomes

Primary Outcomes

30 day readmission

Time Frame: 30 days

Readmissions during the 30 days after the intervention in any hospital centre from the "Àrea Integral de Salut Barcelona Dreta" after consulting the Hospital de la Santa Creu i Sant Pau (HSCSP) emergency department.

Secondary Outcomes

  • Time on Emergency Department(72 hours)
  • 30 day consultation(30 days)
  • 30 day mortality(30 days)

Study Sites (1)

Loading locations...

Similar Trials